Inactive Instrument

Press Releases Tonix Pharmaceuticals Holding Corp OTC Bulletin Board

Equities

TNXP

US8902601025

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

09/07	Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge	MT
09/07	Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

TNX-4200: CD45 Targeted Broad Spectrum Antiviral	16/07	PU
Tonix Pharmaceuticals : Short Investor Presentation July 2024	16/07	PU
Tonix Pharmaceuticals : TNX-102 SL for Fibromyalgia and Long COVID	16/07	PU
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering	11/07	AQ
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya for the Management of Fibromyalgia	09/07	AQ
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering	09/07	AQ
Tonix Pharmaceuticals Announces Proposed Public Offering	09/07	AQ
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia	08/07	AQ
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program	01/07	AQ
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering	29/06	AQ
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering	27/06	AQ
Tonix Pharmaceuticals Announces Proposed Public Offering	27/06	AQ
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement	27/06	AQ
Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024	25/06	AQ
Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia	20/06	AQ
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society	19/06	AQ
Tonix Pharmaceuticals Presented Poster of Tonmya for the Management of Fibromyalgia at the Annual European Congress of Rheumatology 2024	18/06	AQ
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)	18/06	AQ
Tonix Pharmaceuticals Presented Poster of Tonmya™ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024	17/06	AQ
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering	14/06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Tonix Pharmaceuticals Holding Corp OTC Bulletin Board

Equities

TNXP

US8902601025

Press Releases

Filters